Skip to main navigation Skip to search Skip to main content

Phase 11 trial of antologous dendritic cells transferred with a plasmid encoding melanocyte differentiation antigens using a non viral delivery system, CTL901 for the treatment of patients with metatastic melanoma.

Project Details

Short titlePhase 11 trial of antologous dendritic cells transferred with a plasmid encoding melanocyte differentiation antigens using a non viral delivery system, CTL901 for the treatment of patients with metatastic melanoma.
StatusFinished
Effective start/end date1/07/05 → 30/06/07

Funding

  • THE MOULTON CHARITABLE TRUST